Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Lentini Renee, Autre. Director active across 1 company, notably ImmunoGen, Inc.. In total, 12 disclosures have been published. History available since 30 June 2021. The latest transaction was disclosed on 2 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lentini Renee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
14,723 sharesCommon StockSEC:0001104659-24-014710:0
8,435 shares0Common StockSEC:0001415889-24-002870:0
467 shares@ US$16.012.4% of flowCommon StockSEC:0001415889-24-000378:0
15,000 shares0Common StockSEC:0001415889-23-016970:0
9,000 shares@ US$10.7932.5% of flowCommon StockSEC:0001415889-23-014916:0
11,500 shares@ US$3.0511.7% of flowCommon StockSEC:0001415889-23-013290:0
18,218 shares@ US$5.2531.4% of flowCommon StockSEC:0001415889-23-011880:0
3,195 shares@ US$4.054.3% of flowCommon StockSEC:0001415889-23-010824:0
1,351 shares@ US$3.921.8% of flowCommon StockSEC:0001415889-23-000101:0
2,509 shares@ US$3.8253.3% of flowCommon StockSEC:0001415889-22-007323:0
1,957 shares@ US$5.603.7% of flowCommon StockSEC:0001179110-22-000101:0
1,683 shares@ US$5.523.0% of flowCommon StockSEC:0001179110-21-007313:0
About Lentini Renee
Lentini Renee is another declarant linked to ImmunoGen, Inc. as VP & PRIN ACCTG OFFICER. The file shows 12 filings in total, and across the 12 sampled filings the most frequent transaction nature is Attribution, with a range from 2021-07-02 to 2024-02-12 and no reported buy or sell amount in euros.